dc.contributor.author |
Hartkopf, Andreas |
|
dc.contributor.author |
Meier-Stiegen, Franziska |
|
dc.contributor.author |
Hahn, Markus |
|
dc.contributor.author |
Röhm, Carmen |
|
dc.contributor.author |
Hoffmann, Jürgen |
|
dc.contributor.author |
Helms, Gisela |
|
dc.contributor.author |
Ţăran, Florin-Andrei |
|
dc.contributor.author |
Walter, Christina |
|
dc.contributor.author |
Neubauer, Hans |
|
dc.contributor.author |
Wallwiener, Diethelm |
|
dc.date.accessioned |
2013-12-16T10:38:37Z |
|
dc.date.available |
2013-12-16T10:38:37Z |
|
dc.date.issued |
2013 |
|
dc.identifier.issn |
0167-6806 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/39636 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s10549-013-2470-9 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20130911224530_01288 |
de_DE |
utue.publikation.seiten |
509-517 |
de_DE |
utue.personen.roh |
Hartkopf, A. D. |
|
utue.personen.roh |
Banys, M. |
|
utue.personen.roh |
Meier-Stiegen, F. |
|
utue.personen.roh |
Hahn, M. |
|
utue.personen.roh |
Roehm, C. |
|
utue.personen.roh |
Hoffmann, J. |
|
utue.personen.roh |
Helms, G. |
|
utue.personen.roh |
Taran, F. A. |
|
utue.personen.roh |
Wallwiener, M. |
|
utue.personen.roh |
Walter, C. |
|
utue.personen.roh |
Neubauer, H. |
|
utue.personen.roh |
Wallwiener, D. |
|
utue.personen.roh |
Fehm, T. |
|
dcterms.isPartOf.ZSTitelID |
Breast Cancer Research and Treatment |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
138 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |